RIPK1-IN-10
Product Specifications
UNSPSC Description
RIPK1-IN-10 is a potent RIPK1 inhibitor, example 37, extracted from patent WO2021160109[1].
Target Antigen
RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ripk1-in-10.html
Solubility
DMSO : 31.25 mg/mL (ultrasonic;warming;heat to 70°C)
Smiles
O=C(C1CC1)NC2=CN3N=C(C4=CC5=C(N=C4)CCN(CC6=CC(F)=CC(F)=C6OC7CCOCC7)C5=O)C=CC3=N2
Molecular Weight
574.58
References & Citations
[1]Zhou FuSheng, et al. Dihydronaphthyridinone compound, and preparation method therefor and medical use thereof. Patent WO2021160109.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-143728/RIPK1-IN-10-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-143728/RIPK1-IN-10-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2682889-51-4
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal CXCR7/RDC-1 Antibody (358426R) [DyLight 680]](https://cdn.genprice.uk/genprice/genprice4.png)
PSMC2, NT (PSMC2, MSS1, 26S protease regulatory subunit 7, 26S proteasome AAA-ATPase subunit RPT1, Proteasome 26S subunit ATPase 2, Protein MSS1) (PE)
PSMC2, NT (PSMC2, MSS1, 26S protease regulatory subunit 7, 26S proteasome AAA-ATPase subunit RPT1, Proteasome 26S subunit ATPase 2, Protein MSS1) (PE)
